These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36907178)

  • 1. Translation and Validation of the Self-Assessment Psoriasis Area Severity Index.
    Laskowski M; Schiöler L; Wennberg AM; Torén K; Gustafsson H
    Dermatology; 2023; 239(5):794-801. PubMed ID: 36907178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The self-administered psoriasis area and severity index is valid and reliable.
    Feldman SR; Fleischer AB; Reboussin DM; Rapp SR; Exum ML; Clark AR; Nurre L
    J Invest Dermatol; 1996 Jan; 106(1):183-6. PubMed ID: 8592072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis.
    Sampogna F; Sera F; Mazzotti E; Pasquini P; Picardi A; Abeni D;
    Arch Dermatol; 2003 Mar; 139(3):353-8; discussion 357. PubMed ID: 12622629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial.
    Fleischer AB; Feldman SR; Dekle CL
    J Dermatol; 1999 Apr; 26(4):210-5. PubMed ID: 10343464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of psoriasis lesions' location and severity on psychosocial disability and psychopathology. Observational study and psychometric validation of the SAPASI Portuguese version.
    Teixeira A; Ribeiro C; Gaio R; Torres T; Magina S; Pereira T; Teixeira M; Rocha JC; Lobo JMS; Almeida IF; Vidal DG; Pedrosa E Sousa HF; Dinis MAP; Almeida V
    J Psychosom Res; 2022 Mar; 154():110714. PubMed ID: 35007943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
    Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).
    Koek MB; Buskens E; van Weelden H; Steegmans PH; Bruijnzeel-Koomen CA; Sigurdsson V
    BMJ; 2009 May; 338():b1542. PubMed ID: 19423623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported psoriasis severity and quality of life assessment at Comano spa.
    Pagliarello C; Calza A; Di Pietro C; Tabolli S
    Eur J Dermatol; 2012; 22(1):111-6. PubMed ID: 22063458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis.
    Henseler T; Schmitt-Rau K
    Int J Dermatol; 2008 Oct; 47(10):1019-23. PubMed ID: 18986347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and psychologic measures are necessary to assess overall psoriasis severity.
    Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
    J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
    Bożek A; Reich A
    Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial tanning bed treatment is an effective psoriasis treatment: results from an uncontrolled clinical trial.
    Fleischer AB; Clark AR; Rapp SR; Reboussin DM; Feldman SR
    J Invest Dermatol; 1997 Aug; 109(2):170-4. PubMed ID: 9242503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.
    Balato N; Megna M; Di Costanzo L; Balato A; Ayala F
    Br J Dermatol; 2013 Jan; 168(1):201-5. PubMed ID: 23240729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis.
    Yu N; Peng C; Zhou J; Gu J; Xu J; Li X; Bi X; Deng H; Li X; Ding Y; Shi Y
    Br J Dermatol; 2023 Sep; 189(4):437-446. PubMed ID: 37310289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
    Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
    J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    Am J Clin Dermatol; 2017 Aug; 18(4):583-590. PubMed ID: 28342016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Norwegian version of the Quality of Life Scale (QOLS-N). A validation and reliability study in patients suffering from psoriasis.
    Wahl A; Burckhardt C; Wiklund I; Hanestad BR
    Scand J Caring Sci; 1998; 12(4):215-22. PubMed ID: 10067647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis.
    Chularojanamontri L; Griffiths CE; Chalmers RJ
    J Invest Dermatol; 2013 Aug; 133(8):1956-62. PubMed ID: 23807685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
    Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B
    Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
    Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
    J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.